≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other superficial mycoses

EFO Endpoint Browser PheWeb

AB1_OTHER_SUPERF_MYCOSIS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B36
  • Hospital discharge: ICD-9 — 111
  • Hospital discharge: ICD-8 — 111
  • Cause of death: ICD-10 — B36
  • Cause of death: ICD-9 — 111
  • Cause of death: ICD-8 — 111

2 out of 7 registries used, show all original rules.

773

4. Check minimum number of events

None

773

5. Include endpoints

None

773

6. Filter based on genotype QC (FinnGen only)

773

Control definitions (FinnGen only)

Control exclude
AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5932 2806 3076
Only index persons 5363 2569 2794
Unadjusted period prevalence (%)
Whole population 0.08 0.08 0.09
Only index persons 0.10 0.09 0.11
Median age at first event (years)
Whole population 38.43 39.96 37.05
Only index persons 37.82 39.40 36.37

-FinnGen-

Key figures

All Female Male
Number of individuals 773 397 376
Unadjusted period prevalence (%) 0.15 0.14 0.17
Median age at first event (years) 44.35 42.29 46.53

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
676
Matched controls
6762
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B36.0
ICD-10 Finland
Pityriasis versicolor
1025.9
323.0
500
18
J02AB02
ATC
ketoconazole; oral
11.5
34.2
65
62
B36.8
ICD-10 Finland
Other specified superficial mycoses
94.9
33.1
36
*
J02AC02
ATC
itraconazole; systemic
3.5
32.9
185
664
B36.9
ICD-10 Finland
Superficial mycosis, unspecified
92.2
32.0
35
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.0
30.4
105
241
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.1
26.0
166
639
H62.2*B36.9
ICD-10 Finland
Otomycosis NOS
+∞
25.2
24
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.7
22.5
187
844
11100
ICD-8 Finland
Dermatomycosis, other and unspecified, Pityriasis versicolor
+∞
20.9
20
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.6
18.4
88
270
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.3
17.7
95
319
D01AC02
ATC
miconazole; topical
3.7
15.8
71
207
XQ848
NOMESCO Finland
Dermatological photography
6.1
14.7
40
69
E0000UV
ATC
NA
2.0
14.7
276
1758
11199
ICD-8 Finland
Dermatomycosis, other and unspecified, Unspecified
+∞
14.6
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
14.0
263
1663
B36
ICD-10 Finland
Other superficial mycoses
26.3
13.4
18
7
127
Kela drug reimbursment
Transplant complication
9.6
13.1
26
28
B35.3
ICD-10 Finland
Tinea pedis
5.3
12.9
39
77
1110A
ICD-9 Finland
Dermatomycosis, other and unspecified, Pityriasis versicolor
+∞
12.5
12
*
A07EC01
ATC
sulfasalazine; oral, rectal
3.1
12.4
70
242
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.7
12.3
41
91
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
5.2
12.2
37
74
D07AC01
ATC
betamethasone; topical
1.9
11.7
223
1401
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
9.5
11.6
23
25
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.6
11.4
52
154
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
5.1
11.3
35
72
Z94.0
ICD-10 Finland
Kidney transplant status
14.2
11.0
18
13
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
10.7
165
953
L04AA01
ATC
[U] ciclosporin; systemic
7.7
10.7
24
32
L04AX01
ATC
azathioprine; systemic
3.6
10.4
46
133
L04AA06
ATC
mycophenolic acid; systemic
7.3
10.3
24
34
J02AC01
ATC
fluconazole; systemic
1.8
10.3
253
1713
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
10.2
126
667
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
10.2
10.1
19
19
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
9.6
61
230
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
9.3
9.6
19
21
L04AD01
ATC
ciclosporin; systemic
6.3
9.5
24
39
H02AB06
ATC
prednisolone; systemic
1.7
9.4
282
2010
D01AC03
ATC
econazole; topical
3.2
9.1
47
154
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
9.1
170
1047
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
9.0
64
259
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.9
259
1824
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.9
8.9
55
201
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.0
8.9
51
180
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
14.3
8.7
14
10
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.5
8.6
39
116
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.5
8.5
38
112
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
8.5
87
421
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.4
8.4
72
322
TK800
NOMESCO Finland
Hemodialysis
6.3
8.4
21
34
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
8.1
36
106
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.7
7.9
19
29
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
7.9
128
747
H60.3
ICD-10 Finland
Other infective otitis externa
5.0
7.6
23
47
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.6
7.6
52
206
A02BC01
ATC
omeprazole; systemic
1.8
7.5
154
970
L30.0
ICD-10 Finland
Nummular dermatitis
3.9
7.4
29
77
D01BA02
ATC
terbinafine; oral; topical
1.8
7.4
154
972
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.4
223
1568
L04AB04
ATC
adalimumab; parenteral
4.8
7.4
23
49
J01MA02
ATC
ciprofloxacin; systemic
1.6
7.3
230
1632
J01DB01
ATC
cefalexin; oral
1.7
7.3
537
4706
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
7.3
125
740
11180
ICD-8 Finland
Dermatomycosis, other and unspecified, Erythrasma mycoides
+∞
7.3
7
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
7.2
264
1947
L17
ICPC
Foot/toe symptom/complaint
1.7
7.2
149
940
C08CA02
ATC
felodipine; oral
2.7
6.9
46
180
B03XA02
ATC
darbepoetin alfa; parenteral
7.6
6.9
15
20
R03BB04
ATC
tiotropium bromide; inhalant
2.4
6.9
57
249
P01BA02
ATC
hydroxychloroquine; oral
2.5
6.9
54
229
N02BE01
ATC
paracetamol; systemic, rectal
1.7
6.9
535
4708
A02BC02
ATC
pantoprazole; systemic
1.5
6.9
381
3087
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
6.9
210
1477
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
6.9
59
262
UJF32
NOMESCO Finland
Coloscopy
1.8
6.8
137
852
L30.3
ICD-10 Finland
Infective dermatitis
3.8
6.8
27
73
A06AD11
ATC
lactulose; oral
2.2
6.8
67
321
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.7
164
1083
R50.9
ICD-10 Finland
Fever, unspecified
2.0
6.7
91
498
D07AC13
ATC
mometasone; topical
1.6
6.7
179
1214
H02AB04
ATC
methylprednisolone; systemic
1.9
6.7
94
518
S18
ICPC
Laceration/cut
1.6
6.6
234
1705
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.4
6.6
53
231
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.6
6.5
46
186
B35.4
ICD-10 Finland
Tinea corporis
6.3
6.5
16
26
N05CF01
ATC
zopiclone; oral
1.6
6.5
169
1138
B35.1
ICD-10 Finland
Tinea unguium
2.9
6.5
38
138
ZXA00
NOMESCO Finland
Right side
1.7
6.3
143
921
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
11.2
6.3
11
10
R51.80
ICD-10 Finland
Headache
1.8
6.3
100
580
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
6.2
56
259
J45.1
ICD-10 Finland
Nonallergic asthma
2.4
6.1
50
220
SPAT1263
SPAT
Sampling
1.5
6.0
259
1961

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000494) Fungus identified in Specimen by Culture
169
704
2.79
27.80
1.9
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
464
3198
2.13
22.59
11.4
6.2
e9/l
0.2
0.2
0.35
427
2849
(3006315) Basophils [#/volume] in Blood
452
3097
2.11
22.20
10.8
5.9
e9/l
0.0
0.0
1.06
410
2708
(3001604) Monocytes [#/volume] in Blood
449
3092
2.08
21.47
10.7
5.9
e9/l
0.6
0.6
1.95
408
2700
(42870588) Differential panel, method unspecified - Blood
328
2026
2.08
20.97
10.3
6.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
457
3186
2.06
20.90
10.8
5.9
e9/l
2.0
2.0
0.05
420
2849
(3006504) Eosinophils/100 leukocytes in Blood
425
2891
2.04
20.75
10.9
5.9
%
2.8
2.8
0.10
407
2709
(3022096) Basophils/100 leukocytes in Blood
413
2790
2.03
20.45
11.0
6.0
%
0.7
0.7
0.80
395
2620
(3019069) Monocytes/100 leukocytes in Blood
423
2910
2.00
19.58
11.2
6.2
%
8.5
8.4
0.16
407
2746
(3002030) Lymphocytes/100 leukocytes in Blood
432
3005
1.99
19.25
10.9
6.0
%
28.7
28.6
0.06
413
2827
(3018010) Neutrophils/100 leukocytes in Blood
427
2961
1.99
19.17
10.5
5.8
%
57.1
56.7
0.27
407
2797
(3013650) Neutrophils [#/volume] in Blood by Automated count
486
3538
2.01
18.81
14.7
9.1
e9/l
4.1
4.0
0.44
437
3104
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
162
842
2.17
15.65
2.7
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
578
4620
2.00
15.34
11.3
7.3
u/l
74.7
76.3
0.42
557
4359
(3007853) Bacteria identified in Skin by Aerobe culture
138
682
2.25
15.06
2.2
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
31
64
5.00
14.37
1.4
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
337
2309
1.81
14.27
6.9
4.9
g/l
36.0
36.4
0.56
314
2179
(3005322) IgE [Units/volume] in Serum or Plasma
94
410
2.47
13.59
1.4
1.3
u/ml
173.1
170.6
0.02
88
375
(40768443) Skin Pathology biopsy report
63
225
2.96
13.44
1.2
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
526
4180
1.81
12.91
6.0
3.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
341
2410
1.74
12.51
8.7
6.1
mmol/l
1.2
1.2
0.03
313
2219
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
370
2685
1.73
12.27
10.2
6.8
mmol/l
1.2
1.2
0.01
324
2294
(3037522) Nuclear Ab [Titer] in Serum
160
901
1.98
12.21
1.4
1.3
titre
418.7
427.0
0.03
30
179
(3013826) Glucose [Moles/volume] in Serum or Plasma
443
3395
1.71
11.89
6.6
4.7
mmol/l
6.7
6.6
0.36
419
3133
(3005719) IgG [Mass/volume] in Serum or Plasma
99
471
2.26
11.72
3.6
2.5
g/l
10.4
10.3
0.09
90
437
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
403
3021
1.70
11.64
8.0
6.3
umol/l
10.7
11.0
0.46
383
2872
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
334
2382
1.71
11.61
2.9
2.2
nmol/l
73.7
74.2
0.14
311
2174
(3023419) Bacteria identified in Sputum by Culture
27
60
4.63
11.50
3.7
2.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
293
2026
1.72
11.34
4.5
2.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
547
4496
1.74
10.86
7.4
3.8
mm/h
11.6
10.2
1.53
524
4188
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43
140
3.19
10.75
10.5
6.1
iu/ml
178.3
404.2
—
6
20
(3012095) Magnesium [Moles/volume] in Serum or Plasma
154
892
1.91
10.71
5.7
3.4
mmol/l
0.8
0.8
0.25
148
850
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
65
4.27
10.42
1.8
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
265
1818
1.70
10.36
4.0
2.6
u/l
54.4
55.6
0.30
243
1703
(3031040) Bacteria [#/volume] in Urine by Automated count
483
3878
1.65
10.08
5.7
3.8
e6/l
89.8
354.7
—
5
54
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
241
1636
1.69
9.68
3.4
2.0
u/l
152.3
285.3
1.48
229
1553
(3032080) INR in Blood by Coagulation assay
297
2128
1.64
9.68
8.4
7.0
inr
1.1
1.2
2.44
96
657
(3042936) Bacteria identified in Isolate by Culture
140
813
1.88
9.59
3.0
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
80
379
2.24
9.54
2.4
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
216
1430
1.71
9.49
5.7
4.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
92
462
2.13
9.49
6.4
4.1
%
1.4
0.8
0.68
32
136
(40768804) Tissue Pathology biopsy report
327
2410
1.62
9.45
2.2
2.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
84
409
2.18
9.37
6.2
4.3
%
0.0
0.1
0.82
27
106
(3002179) Metamyelocytes/100 leukocytes in Blood
86
423
2.16
9.35
5.8
4.1
%
0.8
0.4
0.53
21
102
(3021440) Promyelocytes/100 leukocytes in Blood
87
433
2.14
9.18
6.5
4.2
%
0.3
0.1
0.40
31
122
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
293
2135
1.60
8.69
4.4
3.4
u/l
31.3
32.2
0.21
278
2043
(3036481) Cortisol [Moles/volume] in Serum or Plasma
105
572
1.97
8.67
2.3
2.0
nmol/l
390.2
373.6
0.17
88
537
(3007164) IgA [Mass/volume] in Serum or Plasma
200
1325
1.69
8.66
1.6
1.4
g/l
2.2
2.3
0.84
127
855
(3009508) Creatinine [Moles/volume] in Urine
251
1774
1.61
8.39
3.8
3.2
mmol/l
7.6
8.4
1.78
210
1510
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
23
58
4.06
8.38
1.9
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
175
1139
1.69
8.04
3.8
2.3
e6/l
3.7
6.3
2.33
159
994
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
553
4716
1.61
7.95
4.4
3.8
pmol/l
14.6
14.5
0.07
505
4340
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
26
75
3.55
7.88
3.3
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
103
578
1.90
7.77
2.5
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
95
520
1.94
7.72
2.4
2.5
g/l
0.2
0.2
0.68
85
491
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
51
218
2.43
7.70
2.0
1.5
iu/ml
3.4
0.0
0.97
11
37
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
73
364
2.11
7.67
4.1
3.0
ng/l
183.9
175.8
0.08
63
321
(3026493) Urate [Moles/volume] in Serum or Plasma
216
1501
1.61
7.63
3.5
2.5
umol/l
1028.5
5961.4
3.23
195
1336
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
12
8.43
7.59
3.4
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
26
77
3.46
7.58
4.5
3.3
%
1.5
1.3
0.19
21
64
(3018418) pH of Serum or Plasma
226
1591
1.59
7.55
7.1
4.1
ph
7.4
7.4
0.06
37
286
(4010399)
78
402
2.05
7.51
1.6
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
239
1710
1.58
7.43
4.1
2.9
e6/l
32.2
82.5
0.69
191
1288
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
50
217
2.39
7.31
3.0
1.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
29
95
3.13
7.23
1.8
1.6
g/l
0.9
0.8
0.20
20
73
(3022948) Iron [Moles/volume] in Serum or Plasma
136
849
1.73
7.22
3.4
2.3
umol/l
12.1
14.0
2.36
131
798
(3026008) Bacteria identified in Urine by Culture
211
1475
1.59
7.21
3.0
2.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
194
1331
1.61
7.16
3.7
3.0
ng/l
1359.2
1005.2
0.68
172
1105
(3030467) Casts [#/volume] in Urine by Automated count
218
1540
1.58
7.11
3.9
2.8
e6/l
0.4
0.4
0.10
169
1127
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
119
718
1.78
7.10
3.6
2.4
%
22.7
24.3
0.53
97
628
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
640
5714
1.70
7.10
5.2
4.4
mu/l
1.8
2.0
0.42
592
5319
(3021601) Nitrite [Presence] in Urine by Test strip
377
3000
1.50
7.08
5.8
4.3
estimate
0.0
0.0
0.50
79
565
(3004588) Protein electrophoresis panel - Serum or Plasma
63
307
2.15
7.02
1.8
2.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
158
1035
1.66
7.00
4.5
3.5
ng/l
103.0
648.3
2.66
107
734
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
278
2083
1.52
6.92
4.1
3.2
ng/l
56.7
40.1
0.34
170
1259
(3009261) Glucose [Presence] in Urine by Test strip
379
3028
1.49
6.92
4.6
3.1
estimate
0.0
0.0
0.50
75
542
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
59
283
2.17
6.85
2.6
2.2
u/l
36.1
38.0
0.38
52
255
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
205
2.38
6.81
2.8
1.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
11
17
6.55
6.79
6.5
4.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
99
573
1.83
6.77
2.5
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
548
4735
1.54
6.77
3.5
3.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
101
590
1.82
6.71
6.4
8.7
mmol/l
1.0
0.9
0.01
85
473
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
134
2.69
6.64
3.3
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
196
1370
1.58
6.63
1.9
1.7
mg/l
0.8
1.0
1.31
137
1010
(3002032) Base excess in Venous blood by calculation
84
465
1.90
6.60
5.9
3.7
mmol/l
2.3
1.9
0.56
67
372
(3018095) Leukocytes [#/volume] in Urine
271
2038
1.51
6.56
4.6
3.4
e6/l
63.5
90.8
0.40
204
1386
(3035350) Ketones [Presence] in Urine by Test strip
372
2983
1.48
6.54
4.5
3.1
estimate
0.0
0.0
0.00
78
546
(3004789) Transferrin [Mass/volume] in Serum or Plasma
124
778
1.71
6.43
3.5
2.3
g/l
2.3
2.4
0.27
119
732
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
51
3.79
6.39
2.6
3.3
%
63.0
55.0
0.71
12
39
(3001122) Ferritin [Mass/volume] in Serum or Plasma
350
2783
1.47
6.37
3.4
2.7
ug/l
111.2
110.2
0.03
331
2610
(3015377) Calcium [Moles/volume] in Serum or Plasma
243
1796
1.51
6.35
3.8
3.3
mmol/l
2.3
2.4
0.43
215
1613
(36304419) Bacteria [Presence] in Urine
212
1524
1.54
6.30
3.8
2.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
27
93
2.97
6.21
3.6
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
101
604
1.77
6.20
14.7
17.8
inr
1.2
1.3
0.20
23
88
(3000991) Gas panel - Venous blood
80
445
1.89
6.20
8.2
8.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
213
1541
1.53
6.12
4.0
3.3
mg/l
847.9
314.9
0.59
145
1016
(3020630) Protein [Mass/volume] in Serum or Plasma
71
381
1.95
6.12
2.2
3.1
g/l
66.9
67.3
0.22
66
357
(3010144) Erythrocytes [#/volume] in Synovial fluid
18
48
3.82
6.11
1.9
1.2
e6/l
9851.7
5920.0
0.32
13
32
(3020682) Albumin/Creatinine [Ratio] in Urine
222
1624
1.51
6.04
4.5
4.1
mg/mmol
10.3
9.5
0.10
146
1049
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
71
384
1.93
5.98
6.3
4.1
ng/l
122.3
81.8
1.11
64
350
(3021589) Normoblasts [#/volume] in Blood
344
2752
1.45
5.94
13.2
8.4
e9/l
0.0
0.0
0.61
285
2250
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
689
6349
1.78
5.94
22.5
11.9
mg/l
18.7
22.2
2.88
571
4925
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
74
407
1.90
5.93
2.4
2.3
ug/l
5.4
8.4
1.07
66
367
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
156
1061
1.59
5.87
1.4
1.3
iu/ml
31.6
30.3
0.05
58
334
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
40
174
2.37
5.86
3.8
2.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
140
928
1.62
5.86
3.0
2.5
e6/l
0.7
1.1
1.26
78
500
(3028026) IgM [Mass/volume] in Serum or Plasma
70
380
1.93
5.84
2.1
1.7
g/l
1.2
1.5
0.62
60
356
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
83
481
1.81
5.66
1.3
1.2
iu/ml
108.4
154.0
0.61
29
196
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
77
3.05
5.57
3.5
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
112
711
1.67
5.54
2.9
2.7
umol/l
6.3
8.3
0.96
90
625
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
33
135
2.51
5.52
3.4
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
213
1572
1.49
5.48
5.4
3.4
estimate
0.0
0.0
1.08
79
551
(3026782) Osmolality of Urine
156
1078
1.56
5.46
3.1
2.4
mosm/kgh2o
530.9
571.3
1.27
137
917
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
61
324
1.96
5.43
5.4
3.2
mmol/l
2.0
1.8
0.15
38
229
(3019550) Sodium [Moles/volume] in Serum or Plasma
684
6322
1.71
5.40
22.1
13.1
mmol/l
139.4
139.7
1.43
673
6161
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
63
339
1.93
5.40
5.4
3.2
kpa
5.2
5.1
0.37
55
318
(3017143) Hepatitis C virus Ab [Presence] in Serum
136
914
1.59
5.36
1.7
1.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
686
6349
1.72
5.35
22.2
13.2
mmol/l
4.0
4.0
2.04
671
6177
(4062490)
19
58
3.33
5.33
1.9
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
78
452
1.81
5.32
4.8
3.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
203
1494
1.49
5.27
8.4
4.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
54
278
2.01
5.25
8.0
12.3
—
—
—
0
0
(44790049)
21
69
3.10
5.25
3.2
1.7
—
—
—
0
0
(44790048)
21
69
3.10
5.25
3.2
1.7
—
—
—
0
0
(44790047)
21
69
3.10
5.25
3.2
1.7
—
—
—
0
0
(44806118)
21
69
3.10
5.25
3.2
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
274
2141
1.43
5.20
2.0
1.9
pmol/l
94.7
94.8
0.01
148
1163
(3011397) Hemoglobin [Presence] in Urine by Test strip
185
1344
1.49
5.11
4.7
3.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
93
2.74
5.05
2.5
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
186
1356
1.49
5.04
2.5
2.1
mg/l
3.0
2.9
0.12
163
1165
(3003327) Ova and parasites identified in Stool by Light microscopy
44
213
2.13
5.04
2.7
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
67
377
1.85
5.03
2.5
3.6
pmol/l
4.4
4.6
1.50
55
340
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
202
1503
1.47
4.93
1.3
1.2
u/ml
2.4
1.6
0.20
47
419
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
106
2.60
4.93
3.4
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
201
1495
1.47
4.91
11.9
6.7
—
—
—
0
0
(3009343) pH of Capillary blood
61
336
1.89
4.89
5.5
3.2
ph
7.4
7.4
—
7
35
(3048689) Calprotectin [Mass/mass] in Stool
127
858
1.57
4.88
3.5
2.5
ug/g
133.1
108.0
0.37
108
688
(3019060) Gas panel - Arterial blood
59
322
1.90
4.87
4.9
6.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
19
62
3.12
4.82
1.4
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
18
57
3.21
4.79
1.6
1.3
g/l
0.4
0.4
0.27
12
39
(3027135) IgG subclass 1 [Mass/volume] in Serum
18
57
3.21
4.79
1.6
1.3
g/l
6.6
6.9
0.18
12
40
(3011412) CD3 cells [#/volume] in Blood
18
57
3.21
4.79
2.3
2.7
e9/l
1.3
1.2
—
9
30
(3028192) IgG subclass 2 [Mass/volume] in Serum
18
57
3.21
4.79
1.6
1.3
g/l
2.9
2.6
0.29
12
39
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
54
289
1.93
4.73
1.9
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
147
1037
1.52
4.64
1.3
1.3
u/ml
22.7
9.3
0.91
52
420
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
291
2336
1.39
4.61
4.8
3.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
174
2.18
4.57
1.9
2.4
g/l
2.7
3.1
1.44
29
142
(40757373) Influenza virus identified in Isolate
8
8
10.09
4.52
3.9
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
62
356
1.81
4.38
1.5
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
184
2.12
4.38
1.9
2.3
g/l
3.7
3.8
0.19
29
139
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
184
2.12
4.38
1.9
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
184
2.12
4.38
1.9
2.3
g/l
7.1
7.3
0.40
30
147
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
95
2.58
4.33
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
95
2.58
4.33
1.1
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
85
537
1.65
4.29
4.0
2.7
%
1.6
1.8
0.83
80
492
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
9
8.97
4.28
5.2
4.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
78
2.74
4.28
2.7
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
643
5932
1.50
4.26
17.2
10.6
ml/min/173m2
87.9
87.8
0.04
554
4831
(3037756) Immunofixation for Serum or Plasma
23
90
2.60
4.25
1.2
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
70
421
1.73
4.24
2.9
2.8
e9/l
5.1
4.1
1.81
56
347
(3048929) Epstein Barr virus Ab [Presence] in Serum
49
264
1.91
4.23
1.4
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
127
886
1.52
4.21
2.9
2.7
e6/l
4.1
2.1
1.04
66
464
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
20
73
2.79
4.21
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
20
73
2.79
4.21
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
178
1329
1.44
4.20
5.3
3.4
kg/l
1.0
1.0
1.25
21
183
(3021960) Folate [Moles/volume] in Serum or Plasma
164
1208
1.45
4.15
1.6
1.5
nmol/l
19.3
20.4
0.44
142
1055
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
17
57
3.03
4.14
3.2
3.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
169
2.12
4.08
1.9
2.4
g/l
10.2
10.7
0.19
30
151
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
15
47
3.23
4.07
1.6
1.3
u/ml
0.6
0.3
—
7
22
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
37
183
2.07
4.05
1.3
1.2
—
1.1
—
0
6
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
31
143
2.22
4.04
1.9
2.5
u/ml
0.2
0.4
2.07
16
71
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
53
3.06
3.98
2.4
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
716
6792
1.73
3.96
15.7
9.4
u/l
28.3
28.1
0.08
706
6600
(3004616) Nuclear Ab [Presence] in Serum
19
70
2.76
3.94
1.5
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
28
125
2.29
3.94
3.8
2.2
mmol/l
24.5
24.3
0.07
21
112
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
35
172
2.08
3.91
1.3
1.2
u/ml
2.4
6.2
—
5
26
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
139
2.21
3.88
1.8
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
54
3.00
3.86
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
54
3.00
3.86
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
54
3.00
3.86
2.4
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
54
3.00
3.86
1.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
150
1101
1.45
3.86
1.7
1.6
pmol/l
189394348.3
20671983.3
0.87
132
953
(3019225) pH of Specimen
79
505
1.63
3.82
5.2
4.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
187
1433
1.40
3.78
2.4
2.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
8
8.82
3.78
4.9
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
610
5608
1.42
3.78
6.4
5.1
mmol/mol
39.8
39.1
1.07
576
5284
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
55
2.95
3.75
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
55
2.95
3.75
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
55
2.95
3.75
1.0
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
56
329
1.76
3.70
2.9
2.2
u/l
9666.1
3802.9
0.40
19
134
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
16
5.68
3.66
4.2
4.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
41
220
1.91
3.61
2.8
1.9
ug/l
2.9
2.1
0.19
36
204
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
62
2.78
3.60
1.0
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
202
1580
1.38
3.60
2.1
1.9
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
32
158
2.07
3.55
6.3
9.6
mmol/l
1.6
1.3
0.64
27
141
(40761511) CBC panel - Blood by Automated count
709
6735
1.64
3.55
17.9
11.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
26
3.88
3.53
2.6
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
27
125
2.20
3.51
3.2
4.0
umol/l
30.0
36.5
1.13
22
107
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
167
1271
1.40
3.50
1.9
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
24
106
2.30
3.48
3.5
2.4
g/l
127.8
132.9
0.40
16
76
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
29
139
2.13
3.47
1.5
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
109
767
1.49
3.47
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
120
2.21
3.42
6.0
3.9
%
60.8
56.5
1.16
26
120
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
38
203
1.92
3.40
2.8
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
464
4121
1.32
3.39
4.2
3.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
62
386
1.66
3.34
2.5
2.7
e9/l
67.2
73.3
0.90
48
294
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
23
102
2.29
3.32
1.5
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
38
3.19
3.22
3.0
2.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
232
1886
1.33
3.17
2.6
2.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
747
7226
2.00
3.14
30.7
17.5
e9/l
258.3
252.9
1.48
739
7072
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
118
2.16
3.13
4.7
3.5
e9/l
4.3
4.2
0.18
25
118
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
21
92
2.32
3.12
2.5
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
86
2.36
3.10
1.2
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
14
50
2.83
3.10
7.4
10.7
mmol/l
9.7
7.1
—
9
40
(3024731) MCV [Entitic volume]
747
7231
1.98
3.06
30.5
17.5
fl
90.9
90.5
1.74
740
7154
(3044290) Cell count panel - Cerebral spinal fluid
26
126
2.10
3.05
1.1
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
372
1.63
3.05
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
183
1444
1.35
3.04
1.7
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
747
7232
1.98
3.04
30.5
17.4
pg
30.3
30.3
0.04
740
7154
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
45
2.92
3.03
1.2
1.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
747
7233
1.97
3.02
30.7
17.5
e12/l
4.6
4.6
0.69
737
7066
(3010813) Leukocytes [#/volume] in Blood
747
7234
1.97
3.00
30.8
17.6
e9/l
6.9
6.7
2.24
738
7065
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
12
40
3.03
2.98
2.7
2.8
%
11.2
13.9
—
5
20
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
57
2.66
2.98
4.5
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
747
7238
1.95
2.93
30.8
17.6
g/l
137.2
138.1
0.91
739
7158
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
52
2.72
2.90
2.3
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
52
2.72
2.90
2.3
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
52
2.72
2.90
2.3
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
151
1.96
2.83
1.5
1.2
u/ml
325.9
219.6
0.76
21
93
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
54
340
1.63
2.82
1.5
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
41
240
1.75
2.80
6.1
3.5
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
19
84
2.29
2.79
1.1
1.3
—
30.1
—
0
5
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
27
138
1.99
2.78
1.2
1.1
u/ml
0.5
2.2
—
10
54
(3019309) Folate [Moles/volume] in Red Blood Cells
116
862
1.41
2.78
1.8
1.6
nmol/l
1233.4
1152.0
0.35
88
682
(36660697) Celiac disease serology panel - Serum
76
523
1.50
2.72
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
501
4562
1.28
2.70
4.2
3.0
u/l
55.3
44.2
1.50
481
4330
(3024932) HLA-DR beta [Type]
8
19
4.24
2.68
1.0
1.2
—
—
—
0
0
(44813793)
12
43
2.82
2.65
1.1
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
35
199
1.79
2.64
1.6
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
38
222
1.75
2.62
6.3
3.7
mmol/l
24.5
25.1
0.50
32
213
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
11
38
2.92
2.59
1.3
1.1
u/l
1.0
1.1
—
6
19
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
26
135
1.96
2.58
2.1
1.5
u/ml
87.9
105.6
0.50
11
29
(3024471) HLA-A [Type]
8
20
4.03
2.57
1.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
7
7.18
2.55
15.0
5.1
mmol/l
4.3
7.5
—
5
7
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
101
2.11
2.55
1.1
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
11
5.49
2.54
1.2
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
209
1725
1.29
2.49
3.7
2.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
26
3.49
2.48
3.9
3.2
—
—
—
0
0
(3013512) EKG study
187
1521
1.30
2.48
4.3
3.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
16
4.40
2.48
1.0
4.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
29
159
1.86
2.47
3.4
3.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
159
1.86
2.47
1.4
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
14
57
2.48
2.46
1.1
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
56
370
1.55
2.43
1.6
1.4
iu/l
24.9
22.5
0.24
46
313
(3000093) Morphology [Interpretation] in Blood Narrative
11
40
2.78
2.38
1.3
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
58
2.44
2.38
1.3
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
111
2.01
2.37
4.0
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
118
1.98
2.37
1.0
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
22
3.66
2.37
4.1
2.1
ug/l
55.9
102.2
—
8
22
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
46
2.63
2.36
1.8
3.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
78
2.21
2.32
1.9
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
328
2876
1.24
2.32
4.7
3.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
85
2.14
2.30
1.2
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
23
3.50
2.27
4.6
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
79
2.18
2.26
1.9
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
79
2.18
2.26
1.9
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
66
2.30
2.25
4.5
3.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
667
6363
1.35
2.20
5.0
4.4
mmol/l
2.7
2.8
1.83
632
5969
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
634
6005
1.31
2.20
4.6
4.0
mmol/l
5.9
5.9
0.59
584
5569
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
24
3.36
2.18
2.3
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
8
24
3.36
2.18
4.0
4.0
—
32.4
—
0
6
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
88
652
1.39
2.17
8.0
6.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
30
174
1.75
2.16
3.9
2.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
74
2.19
2.16
3.1
2.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
30
3.02
2.15
1.0
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
30
3.02
2.15
1.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
72
517
1.43
2.12
4.8
3.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
41
261
1.60
2.11
4.4
2.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
146
1.81
2.09
1.3
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
146
1.81
2.09
2.3
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
31
2.92
2.07
1.0
1.1
miu/ml
2075.6
1616.5
—
9
31
(3014148) Varicella zoster virus Ab [Titer] in Serum
19
96
2.00
2.07
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
20
3.52
2.06
2.4
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
118
1.89
2.03
1.3
1.1
—
—
—
0
0
(3020891) Body temperature
32
193
1.69
2.03
7.2
4.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
79
582
1.40
2.02
1.5
1.5
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
9
32
2.83
2.00
1.4
1.8
iu/ml
—
1224630.0
—
0
5
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
13
57
2.30
1.98
2.0
2.2
e6/l
729.8
723.1
—
6
22
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
24
134
1.82
1.97
1.9
4.5
mg/l
80.4
32.3
0.58
19
115
(3034860) Kappa light chains.free [Mass/volume] in Serum
24
134
1.82
1.97
1.9
4.5
mg/l
48.9
96.8
0.52
18
114
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
76
561
1.39
1.93
3.5
2.4
u/l
35.6
122.5
0.52
67
486
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
78
2.07
1.92
1.9
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
23
129
1.81
1.87
1.1
1.1
u/ml
1.9
7.8
2.05
11
68
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
79
2.05
1.86
1.9
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
79
2.05
1.86
1.9
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
17
86
2.00
1.86
2.2
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
46
2.41
1.86
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
46
2.41
1.86
1.1
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
40
262
1.56
1.85
2.0
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
21
115
1.85
1.84
5.5
2.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
145
1.75
1.83
2.9
2.4
ug/min
23.0
103.7
1.52
15
84
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
199
1.63
1.83
1.3
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
12
4.19
1.82
7.4
3.0
%
51.9
51.7
—
5
12
(3008401) Mugwort IgE Ab [Units/volume] in Serum
22
123
1.81
1.81
1.1
1.1
u/ml
0.4
1.9
—
8
51
(3021901) Oxygen saturation in Capillary blood
16
80
2.02
1.81
4.7
2.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
35
2.59
1.80
3.2
2.7
u/ml
488.0
715.1
—
9
35
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
115
915
1.30
1.80
2.8
2.8
mmol/l
2.4
2.4
0.25
97
808
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
47
2.36
1.78
1.6
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
62
449
1.41
1.77
3.9
2.5
ml/min/173m2
71.1
73.8
0.16
25
181
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
33
209
1.60
1.76
1.9
2.0
%
96.9
91.0
0.97
33
191
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
54
2.24
1.74
1.2
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
656
6291
1.28
1.71
4.6
4.0
mmol/l
4.6
4.7
3.28
629
5938
(3022621) pH of Urine by Test strip
52
367
1.45
1.71
2.6
2.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
48
2.31
1.71
1.3
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
25
2.82
1.65
1.3
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
38
254
1.52
1.63
1.4
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
18
98
1.86
1.62
2.2
4.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
43
2.34
1.61
1.1
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
183
1.61
1.59
1.2
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
20
3.01
1.58
2.7
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
26
2.71
1.58
2.7
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
72
547
1.35
1.57
5.0
2.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
17
92
1.87
1.57
3.1
2.8
u/ml
4.2
6.1
0.48
17
84
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
57
2.12
1.55
1.2
1.5
g/l
0.9
1.0
0.74
12
57
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
33
2.44
1.54
1.0
1.1
iu/ml
187.0
162.4
—
8
33
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
185
1.59
1.53
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
37
250
1.50
1.53
2.2
2.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
21
123
1.73
1.52
4.2
3.9
mg/l
14.2
24.7
1.66
11
77
(3006653) Thiamine [Moles/volume] in Blood
7
27
2.61
1.51
1.4
1.3
nmol/l
123.9
141.7
—
7
27
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
7
27
2.61
1.51
1.4
1.6
nmol/l
1.1
9.1
—
7
22
(3047007) Chlamydophila sp Ab [Presence] in Serum
20
116
1.74
1.50
1.4
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
37
2.45
1.48
1.3
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
188
1.56
1.45
1.2
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
22
2.74
1.43
1.0
2.5
u/l
226.5
190.4
—
6
22
(3022145) Colonoscopy Study observation
86
683
1.29
1.39
1.7
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
60
2.02
1.38
1.8
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
43
307
1.42
1.37
3.3
1.9
—
—
—
0
0
(4027681)
9
41
2.21
1.37
1.2
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
23
2.62
1.37
1.7
2.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
17
2.95
1.36
1.2
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
17
2.95
1.36
1.6
3.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
98
796
1.26
1.34
1.6
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
29
192
1.53
1.34
2.0
2.2
%
170.1
172.7
0.05
29
183
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
32
217
1.50
1.32
1.7
1.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
36
251
1.46
1.31
5.2
2.8
%
0.6
0.7
1.01
36
245
(3017446) Testosterone [Moles/volume] in Serum or Plasma
71
555
1.31
1.30
2.3
2.2
nmol/l
13.9
13.7
0.07
64
511
(40768441) Liver Pathology biopsy report
9
43
2.11
1.30
2.0
1.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
9
43
2.11
1.30
1.9
2.4
—
1.4
—
0
5
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
153
1.59
1.30
1.5
1.5
ug/g
279.5
298.3
0.17
14
96
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
220
1947
1.18
1.29
4.5
4.2
ug/l
1.9
2.1
0.22
201
1770
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
69
1.90
1.29
1.5
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
18
2.79
1.28
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
649
6264
1.22
1.28
4.5
4.0
mmol/l
1.4
1.4
1.26
617
5892
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
48
2.10
1.28
5.0
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
19
115
1.67
1.25
1.0
1.1
iu/ml
78.7
66.0
—
7
29
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
17
100
1.72
1.24
1.7
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
147
1.58
1.24
1.8
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
49
2.05
1.22
1.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
19
2.64
1.21
1.2
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
19
2.64
1.21
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
51
385
1.35
1.20
1.6
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
26
2.32
1.19
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
635
6128
1.20
1.18
20.4
12.7
%
41.1
40.6
1.12
481
4836
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
141
1.58
1.18
1.9
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
19
118
1.63
1.15
4.6
3.4
mmol/l
1.9
2.4
—
9
74
(3023511) Choriogonadotropin [Units/volume] in Urine
27
184
1.48
1.12
1.4
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
16
96
1.68
1.11
3.4
2.3
umol/l
6.9
5.1
0.34
11
69
(3035320) C reactive protein [Mass/volume] in Body fluid
8
41
1.96
1.09
3.5
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
184
1627
1.17
1.09
1.7
1.7
mmol/l
1.4
1.4
0.16
156
1406
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
52
402
1.31
1.06
6.6
3.5
mmol/l
1.2
1.2
0.15
42
353
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
21
137
1.55
1.06
1.2
1.6
e6/l
188.5
1394.0
0.69
15
113
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
21
137
1.55
1.06
1.1
1.5
e6/l
2.9
11.6
0.99
14
110
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
187
1.46
1.05
1.1
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
5
22
2.28
1.03
1.0
1.3
nmol/l
74.8
123.9
—
5
15
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
47
1.93
1.02
1.6
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
47
1.93
1.02
1.8
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
625
6045
1.18
1.02
4.2
3.6
mmol/l
1.4
1.3
1.42
590
5675
(3018405) Lactate [Moles/volume] in Arterial blood
26
180
1.46
1.02
4.6
4.2
mmol/l
1.3
1.3
0.01
26
174
(3030981) Hyaline casts [#/volume] in Urine by Automated count
40
300
1.35
1.01
4.3
2.7
e6/l
0.6
0.1
0.73
40
292
(21494890) Protein electrophoresis panel - 24 hour Urine
9
48
1.89
1.00
2.3
3.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
23
2.18
0.98
1.0
1.0
u/ml
110.3
26.8
—
5
23
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
23
2.18
0.98
1.2
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
124
1.55
0.97
2.1
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
116
1.56
0.97
1.6
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
36
1.95
0.97
1.0
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
12
69
1.75
0.97
1.1
1.3
mu/l
62.8
44.2
—
7
64
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
61
490
1.27
0.96
3.2
4.4
ug/l
2.8
21.1
1.13
46
403
(3009214) Lutropin [Units/volume] in Serum or Plasma
33
243
1.37
0.94
1.5
1.4
u/l
9.4
9.0
0.05
24
200
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
37
1.90
0.94
4.4
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
17
109
1.57
0.94
1.2
1.0
u/ml
0.8
1.8
—
7
51
(3028433) Virus identified in Specimen by Culture
6
27
2.23
0.93
1.8
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
243
0.65
0.91
1.3
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
28
2.15
0.91
2.2
1.4
u/l
10.2
16.0
—
6
28
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
242
0.65
0.90
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
242
0.65
0.90
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
242
0.65
0.90
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
81
679
1.22
0.88
1.9
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
15
95
1.59
0.88
4.3
2.1
%
15.7
16.9
—
9
42
(3000764) Benzodiazepines [Presence] in Urine
49
388
1.28
0.87
3.3
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
35
264
1.34
0.87
2.8
3.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
43
1.87
0.87
2.3
1.9
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
30
2.01
0.87
1.2
1.4
—
26.6
—
0
5
(3027008) Opiates [Presence] in Urine
49
391
1.27
0.83
3.3
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
46
1.75
0.82
5.4
4.5
%
12.1
11.2
—
8
46
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
11
65
1.70
0.82
1.5
1.4
mmol/l
9.4
12.6
—
6
15
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
260
0.68
0.82
1.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
81
1.62
0.81
1.3
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
40
313
1.29
0.79
1.9
1.6
mu/l
317.4
304.9
0.08
32
287
(3002385) Erythrocyte distribution width [Ratio]
569
5500
1.13
0.79
24.6
14.5
%
13.6
13.5
1.01
562
5389
(3028300) Cannabinoids [Presence] in Urine
49
394
1.26
0.79
3.3
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
66
1.68
0.79
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
48
1.67
0.79
2.8
2.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
172
1552
1.14
0.78
4.3
3.7
%
21.6
21.3
0.07
66
662
(40768800) Prostate Pathology biopsy report
16
107
1.51
0.76
1.1
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
34
1.77
0.76
1.5
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
101
878
1.17
0.76
1.8
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
38
1.85
0.73
1.3
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
176
1.38
0.73
1.6
1.9
iu/l
4.4
5.6
—
6
57
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
25
2.01
0.72
1.0
2.1
%
—
74.2
—
0
6
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
25
2.01
0.72
1.2
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
25
2.01
0.72
1.0
1.1
—
15.2
—
0
7
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
109
0.55
0.72
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
236
2542
0.90
0.71
2.6
2.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
85
1.54
0.69
1.6
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
69
1.60
0.68
1.3
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
45
366
1.24
0.68
3.5
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
72
615
1.19
0.68
1.9
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
32
406
0.78
0.67
1.3
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
76
878
0.85
0.65
1.3
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
62
1.62
0.65
3.0
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
14
200
0.69
0.63
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
14
199
0.70
0.62
1.3
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
2.8
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
2.8
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
2.8
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
2.8
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
113
1.42
0.61
4.0
4.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
192
1.31
0.60
2.1
2.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
15
106
1.42
0.58
4.5
5.8
umol/l
340.1
363.0
0.22
15
95
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
78
682
1.16
0.57
4.2
4.1
%
30.3
31.0
0.24
60
482
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
35
1.72
0.57
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
29
229
1.28
0.57
1.3
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
125
1130
1.13
0.57
2.2
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
117
1056
1.13
0.55
1.7
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
205
0.73
0.55
1.3
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
26
204
1.28
0.54
1.5
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
38
1.58
0.54
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
38
1.58
0.54
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
46
387
1.20
0.53
3.3
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
232
1.26
0.53
1.4
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
43
510
0.83
0.52
1.4
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
63
1.43
0.52
1.0
1.0
—
—
—
0
0
(4198724)
6
40
1.50
0.51
5.2
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
46
1.53
0.48
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
56
486
1.16
0.47
1.9
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
97
876
1.12
0.47
1.6
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
49
1.43
0.46
1.7
3.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
103
1.37
0.45
1.2
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
24
297
0.80
0.45
1.7
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
86
1.40
0.44
1.5
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
140
1.29
0.42
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
5.8
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
65
728
0.88
0.41
1.5
1.7
—
—
—
0
0
(4035726)
53
465
1.15
0.40
2.0
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
123
1.31
0.40
1.0
1.5
nmol/l
0.5
0.4
0.46
11
102
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
112
1030
1.10
0.40
2.2
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
132
1.29
0.40
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
68
1.33
0.37
2.4
1.3
nmol/l
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
21
170
1.24
0.37
1.8
1.8
pmol/l
225.2
224.8
0.00
21
160
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
116
0.69
0.37
2.4
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
135
1.27
0.35
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
39
339
1.16
0.35
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
106
982
1.09
0.34
1.9
1.8
%
1.5
1.4
0.16
96
890
(3002256) Pathology report gross observation
80
732
1.10
0.33
1.3
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
155
1.23
0.32
1.6
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
101
1.29
0.32
1.2
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
165
1.22
0.31
1.2
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
97
0.72
0.31
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
98
0.71
0.31
1.0
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
57
1.23
0.29
1.4
1.8
pg
30.7
33.3
—
7
57
(4268621)
10
76
1.32
0.28
1.7
2.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
150
0.80
0.27
1.1
1.6
—
—
—
0
0
(4034850)
22
187
1.18
0.27
12.3
10.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
66
1.21
0.26
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
13
104
1.25
0.26
1.1
1.1
%
125.6
117.2
0.43
13
95
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
17
141
1.21
0.26
5.1
2.1
nmol/l
0.8
0.9
0.24
17
121
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
40
358
1.12
0.26
1.1
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
72
1.25
0.25
2.3
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
114
1.23
0.25
1.4
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
75
1.20
0.25
1.6
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
10
78
1.29
0.24
1.0
1.1
%
109.2
94.2
—
10
73
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
10
78
1.29
0.24
2.3
1.3
nmol/l
0.6
0.6
—
10
73
(3051651) Icteric interference index of Serum or Plasma
5
38
1.32
0.23
1.6
3.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
17
144
1.18
0.22
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
17
144
1.18
0.22
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
122
1161
1.06
0.22
2.9
2.7
ug/l
0.6
0.7
1.59
76
702
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
2.5
—
0.4
—
0
10
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
53
1.13
0.18
1.2
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
32
290
1.11
0.18
3.1
2.4
u/ml
42.3
41.4
0.02
32
279
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
110
1.18
0.17
1.3
1.3
u/ml
1.2
4.0
—
6
37
(3032773) Endomysium IgG Ab [Titer] in Serum
7
63
1.11
0.17
1.3
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
67
0.74
0.17
1.8
2.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
101
1.19
0.16
7.3
2.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
41
442
0.92
0.16
1.5
1.5
—
—
—
0
0
(4306422)
13
111
1.17
0.16
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
30
275
1.09
0.14
1.4
1.3
miu/ml
167.6
242.2
0.56
13
139
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
138
0.87
0.13
2.2
1.8
—
—
—
0
0
(4024509)
5
44
1.14
0.10
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
20
186
1.08
0.07
1.6
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
85
1.06
0.07
1.0
1.1
—
—
—
0
0
(4094501)
14
152
0.92
0.06
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
30
286
1.05
0.06
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
32
306
1.05
0.05
1.7
1.7
mg/l
2.6
3.2
0.26
24
217
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
110
1.09
0.05
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
191
1928
0.99
0.04
1.6
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
25
241
1.04
0.02
1.8
1.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
12
113
1.06
0.02
1.3
1.4
u/l
16.8
22.4
—
7
97
(1761482) Bacteria [#/volume] in Urine by Culture
14
135
1.04
0.00
3.2
3.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
30
296
1.01
0.00
1.7
1.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
197
1.02
0.00
4.8
3.8
g/l
0.2
0.3
—
9
93
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
15.4
—
0
5
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
4.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
58
0.86
0.00
1.2
2.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
61
0.98
0.00
1.5
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
6.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
67
0.89
0.00
1.7
2.4
mmol/l
106.0
105.6
—
6
67
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
15.7
—
0.3
—
0
9
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
14.0
—
0
6
(3041354) Potassium [Moles/volume] in Venous blood
6
67
0.89
0.00
1.7
2.4
mmol/l
4.0
4.0
—
6
67
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
59
1.02
0.00
1.2
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
6
0.00
0.00
0.0
1.3
—
320.3
—
0
6
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_OTHER_SUPERF_MYCOSIS and mortality.

Females

Parameter HR [95% CI] p-value
AB1_OTHER_SUPERF_MYCOSIS 1.458 [1.17, 1.82] < 0.001
Birth year 0.993 [0.98, 1.0] 0.101

During the follow-up period (1.1.1998 — 31.12.2019), 162 out of 1804 females with AB1_OTHER_SUPERF_MYCOSIS died.

Males

Parameter HR [95% CI] p-value
AB1_OTHER_SUPERF_MYCOSIS 1.789 [1.46, 2.2] < 0.001
Birth year 0.986 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 270 out of 1925 males with AB1_OTHER_SUPERF_MYCOSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_OTHER_SUPERF_MYCOSIS.

N-year risk Females Males
1 0.135% 0.398%
5 0.8% 2.169%
10 2.085% 5.0%
15 4.018% 9.478%
20 7.086% 15.894%

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_SUPERF_MYCOSIS – Other superficial mycoses

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data